MCPMF Stock Financial Analysis - Mochida Pharmaceutical Co., Ltd. (OTCPK) Stock

Mochida Pharmaceutical Co., Ltd.
US ˙ OTCPK ˙ JP3922800002
THIS SYMBOL IS NO LONGER ACTIVE

Overview
Mochida Pharmaceutical Co., Ltd., based in Japan, operates primarily within the pharmaceutical industry, focusing on the development, manufacture, and sale of prescription drugs and medical devices. A significant portion of its portfolio emphasizes dermatology, cardiovascular diseases, and women’s health, underscoring a commitment to diverse and specialized healthcare solutions. Mochida also actively engages in collaborations and partnerships to bolster its research and development capabilities, demonstrating a strategy to innovate consistently in therapeutic fields. The company’s commitment to high ethical standards and sustainable practices further characterizes its operations, aligning with broader industry trends towards responsible corporate conduct in the healthcare sector.
Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
Income Statement: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
Cash Flow: Operations, Investing, Financing
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
Valuation Metrics : PE, PriceToBook, PriceToTBV
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) EBIT/EV EBIT (3y)/EV
Management Effectiveness
Period End (TTM) ROA ROE ROIC CROIC OCROIC
Gross Margins
Gross Margin
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Net Margin
The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
Operating Margin
The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) Gross Margin Net Margin Operating Margin
Identifiers and Descriptors
Central Index Key (CIK)
Industry Groups
Other Listings
JP:4534 ¥3,235.00
DE:MFY €18.30
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista